Jennifer Anisko
Pediatrics · Baltimore, MDNPI 1659586709
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,424 and has fallen 70.6% since, to $418 in 2025. Among pediatrics clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$907
- Dexcom, Inc.$648
- Lilly USA, LLC$302
- Sanofi-aventis U.S. LLC$218
- Xeris Pharmaceuticals, Inc.$187
- Rhythm Pharmaceuticals, Inc.$173
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,392100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $907 |
| Dexcom, Inc. | 23 | $648 |
| Lilly USA, LLC | 16 | $302 |
| Sanofi-aventis U.S. LLC | 10 | $218 |
| Xeris Pharmaceuticals, Inc. | 9 | $187 |
| Rhythm Pharmaceuticals, Inc. | 7 | $173 |
| Mannkind Corporation | 6 | $147 |
| Tolmar, Inc. | 5 | $140 |
| Tandem Diabetes Care, Inc. | 5 | $137 |
| AstraZeneca(2 entities) | 6 | $136 |
| Pfizer | 6 | $133 |
| BETA Bionics, Inc. | 3 | $131 |
| AbbVie | 5 | $114 |
| Ascendis Pharma Endocrinology Inc | 4 | $110 |
| Abbott | 5 | $95 |
| Amphastar Pharmaceuticals, Inc. | 4 | $94 |
| Bayer | 3 | $70 |
| Zealand Pharma US, Inc. | 3 | $61 |
| Insulet Corporation | 2 | $53 |
| Amneal Pharmaceuticals LLC | 2 | $48 |
| Kyowa Kirin, Inc. | 2 | $47 |
| Ultragenyx Pharmaceutical Inc. | 2 | $45 |
| Medtronic | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Averitas Pharma Inc. | 2 | $40 |
| Lifescan, Inc. | 2 | $37 |
| Recordati_rare_diseases_inc. | 2 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Boehringer Ingelheim | 1 | $28 |
| BD | 1 | $26 |
| Intuity Medical Inc | 1 | $25 |
| Tolmar Pharmaceuticals, Inc. | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $20 |
| Eton Pharmaceuticals, Inc. | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$350
- Sogroya$122
How this compares
$4,392 in reported general payments places this provider in the 95th percentile of 1,307 pediatrics providers in Maryland.
Other pediatrics in Baltimore
- Mary Elizabeth YoungerBaltimore$130K
- Brenda BanwellBaltimore$109K
- John ThomsonBaltimore$67K
- Carmelo CuffariBaltimore$61K
- Deborah PersaudBaltimore$22K
- Eric McCollumBaltimore$18K
- Irini BatsisBaltimore$14K
- Kim DrucisBaltimore$10K
- Maria TrentBaltimore$9K
- Nicole Salazar AustinBaltimore$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.